title: Long-term clinical course with voltage-gated potassium channel antibody in Morvan's syndrome.
authors.forename: Nam-Hee
authors.initials: NH
authors.lastname: Kim
authors.forename: Angela
authors.initials: A
authors.lastname: Vincent
authors.forename: Saroshi R
authors.initials: SR
authors.lastname: Irani
authors.forename: Sang Eun
authors.initials: SE
authors.lastname: Kim
authors.forename: Kwang-Woo
authors.initials: KW
authors.lastname: Lee
authors.forename: Kyung Seok
authors.initials: KS
authors.lastname: Park
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D020386:Isaacs Syndrome / Q000276:immunology* / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D010951:Plasma Exchange; D024642:Potassium Channels, Voltage-Gated / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D007166:Immunosuppressive Agents; D024642:Potassium Channels, Voltage-Gated
references.citation: Ann Neurol. 2011 Feb;69(2):303-11
references.pmid: 21387375
references.citation: Lancet Neurol. 2011 Aug;10(8):759-72
references.pmid: 21777830
references.citation: J Clin Neuromuscul Dis. 2012 Jun;13(4):214-27
references.pmid: 22622167
references.citation: Brain. 2010 Sep;133(9):2734-48
references.pmid: 20663977
references.citation: Ann Neurol. 2012 Aug;72(2):241-55
references.pmid: 22473710